Cases
Representative Matters: Represented DuPont (NYSE: DD) in the sale of its Solamet business, which manufactures solar cell paste to deliver higher solar energy efficiency, to a private equity-sponsored business in China.
Represented Firmenich Inc., one of the world's largest producers of flavors
fragrances, in connection with its minority investment in a strategic target with an option to acquire the remainder of the company.
Represented financial services
investment firm Cohen & Company Inc. (NYSE American: COHN), as issuer, in its $75 million at-the-market offering, with Northl
Capital Markets as sales agent.
Represented Virios Therapeutics, Inc. (Nasdaq: VIRI), a biotechnology company focused on advancing antiviral therapies to treat diseases associated with an abnormal immune response, such as fibromyalgia, in its initial public offering.
Represented Annovis Bio, Inc. (NYSE American: ANVS ), a manufacturer of pharmaceuticals for the treatment of neurodegenerative diseases, in connection with its initial public offering.
Represented DuPont (NYSE: DD), a global innovation leader with technology-based materials, in its $110 million acquisition of Evoqua's Memcor business, which includes ultrafiltration
membrane bio-filtration technologies.
Represented Mannington Mills, a leading manufacturer of fine flooring, in its acquisition of Phenix Flooring
Pharr Fibers
Yarns, a leader in the flooring industry
pioneer in the solution-dyed arena, from Pharr USA.
Represented certain investors in a $361 million investment into Covetrus, Inc., a spin out comprised of assets from Henry Schein, Inc. (a publicly traded company)
Vets First Choice (a private equity backed company), as part of a larger $1.5 billion transaction.
Represented Firmenich, Inc., one of the world's largest producers of flavors
fragrances, in its acquisition of Natural Flavors, Inc., a producer of natural
organic flavor products.
Represented IQVIA (formerly QuintilesIMS), a leading world-wide integrated information
technology-enabled healthcare service provider, in connection with the acquisition of 100 percent of the outst
ing membership interests of Chemical Information Services, LLC, a private equity-backed-Dallas-based technology company that provides online databases for chemical
pharmaceutical companies.
Represented Firmenich, Inc., one of the world's largest producers of flavors
fragrances, in connection with its acquisition of Agilex Holdings, Inc., a portfolio company of New York-based private equity firm MidOcean Partners.
Represented the special committee of the Board of Directors of JAVELIN Mortgage Investment Corp. (NYSE: JMI) in a merger agreement in which ARMOUR Residential REIT, Inc. (NYSE: ARR) will acquire JAVELIN,
its $900 million of assets, in a tender offer for cash consideration based on 87% of JAVELIN's book value per share.
Advised Hill International (NYSE:HIL), a Philadelphia-based project management company, in the sale of its Construction Claims Group to UK-based private equity firm Bridgepoint Development Capital for $147 million.
Advised Firmenich on US diligence
regulatory matters in connection with its agreement to acquire Les Derives Resiniques et Terpeniques (DRT), a world leader in plant-based chemistry,
a leading global supplier of renewable ingredients, from private equity owners Ardian Buyout
Tikehau Capital
family shareholders.
Represented SunPower (NASDAQ: SPWR), a solar energy company, in its $75 million strategic divestiture of its microinverter assets (including more than 140 patents)
SunPower's long-term supply agreement with Enphase Energy (NASDAQ: ENPH).
Represented Voxx International Corporation in its $20 million acquisition, through Newco, a Delaware LLC, of 54 percent of the assets of EyeLock, Inc., a Puerto Rico corporation,
EyeLock Corporation, a Delaware corporation,
a wholly-owned subsidiary of EyeLock, Inc.
Represented Hill International Inc., a global leader in managing construction risk, in a $165 million debt refinancing transaction.
Represented VEREIT, Inc. (NYSE: VER) a NYSE-traded REIT, in a merger transaction valued at $3.1 billion to acquire American Realty Capital Trust IV, Inc., a non-traded REIT. The combined company as a result of the merger had pro forma enterprise value of $10 billion.
Represented National Securities Corporation, as underwriter
sole book running manager, in connection with the initial public offering by CBD Energy Limited, a diversified clean energy company
leading provider of solar installations worldwide.
Represented VEREIT, Inc. (NYSE: VER) a NYSE-traded REIT, in a merger transaction valued at $3.2 billion to acquire American Realty Capital Trust III, Inc., a non-traded REIT. The combined company as a result of the merger had pro forma enterprise value of $10 billion.
Represented Lehigh Gas Partners LP, a wholesale motor fuel distributor now known as CrossAmerica Partners LLP, in connection with its $138 million IPO.
Represented a subsidiary of a French rail operator in a $12 million sale of its U.S. bus tour business.
Represented Iroko Pharmaceuticals, LLC in connection with a $140 million secured loan facility with CRG, a healthcare investment fund,
the simultaneous pay-off of Iroko's loan facility with another lender.
Represented a specialty chemical company, a portfolio company of a large private equity firm, in closing a $175 million credit facility, comprised of revolving credit, term loan, swing line
letters of credit sub-facilities. The credit agreement contained an accordion feature affording the client the right to increase the revolving credit facility size by $50 million. Also represented the company in its first bolt-on strategic acquisition with a transaction value of approximately $25 million.
Represented a Nasdaq-listed retail department store company in a $1 billion acquisition
the related offering of $600 million in debt securities.
Represented a national home renovation company in connection with a shareholder buyout
reorganization.
Represented middle market private equity firm in multiple control
minority investments, recapitalizations
dispositions.
Represented an NYSE-listed health care real estate investment trust in multiple public offerings of debt securities, common stock
preferred stock.
Represented a private equity fund-backed security services company in multiple acquisitions.
Represented a national door manufacturer in a $700 million recapitalization.
Represented an NYSE-listed national home building company in general securities
governance matters as well as multiple public offerings of securities of more than $1 billion, including private issuances of debt securities
the related exchanges for registered debt securities.
Represented an NYSE-listed pipeline company in an issuer tender offer of common stock.
Represented a privately held financial services firm in its acquisition of a Nasdaq-listed specialty finance company in an equity exchange
was retained as securities
M&A counsel to the resulting public company.
Represented a publicly traded financial services firm in multiple acquisition
disposition transactions, including the acquisitions of a full-service investment bank
a specialty broker-dealer
the dispositions of multiple asset management businesses.
Represented a publicly traded financial services firm in a public debt-exchange transaction.
Represented a publicly traded manufacturing company in its acquisition of a privately held manufacturing company for approximately $100 million.
Represented a Nasdaq-listed company in multiple acquisitions, a $50 million follow-on offering of common stock
the sale of the company to an industry competitor.
